Board Committees

Currently the VP of Business Operations & Site Lead for Medtronic PLC’s Caesarea site (formerly Mazor Robotics), Sharon is medical device veteran with extensive financial and business management experience in developing successful companies.

Mr. Chan has been a private equity executive for the past three decades, managing and leading more than 80 investment projects supporting company growth via funding and synergistic mergers and acquisitions. Since March 2021, he has been the Director of Samena Capital, a principal investment group, headquartered in Dubai, with three private equity funds and $390 million in assets under management, and was a Senior Managing Director and Head of Asia of Samena Capital Hong Kong Limited from 2016 to 2021.

Mr. Yonatan Malca has served on our board of directors as an external director since September 2025. is the chief executive officer and a director at NanoGhost Ltd., a private biotechnology company. He serves on the board of directors of Entera Bio (NASDAQ: ENTX) and holds additional board positions at BeamMed Ltd., a private medical device company, Jungo Connectivity (TASE: JNGO), and Unicorn Technologies (TASE: UNCT). Mr. Malca holds a B.A. in Economics and Statistics and an M.A. in Economics and Finance, both from Bar-Ilan University in Israel.

Mr. Yonatan Malca has served on our board of directors as an external director since September 2025. is the chief executive officer and a director at NanoGhost Ltd., a private biotechnology company. He serves on the board of directors of Entera Bio (NASDAQ: ENTX) and holds additional board positions at BeamMed Ltd., a private medical device company, Jungo Connectivity (TASE: JNGO), and Unicorn Technologies (TASE: UNCT). Mr. Malca holds a B.A. in Economics and Statistics and an M.A. in Economics and Finance, both from Bar-Ilan University in Israel.

Mr. Chan has been a private equity executive for the past three decades, managing and leading more than 80 investment projects supporting company growth via funding and synergistic mergers and acquisitions. Since March 2021, he has been the Director of Samena Capital, a principal investment group, headquartered in Dubai, with three private equity funds and $390 million in assets under management, and was a Senior Managing Director and Head of Asia of Samena Capital Hong Kong Limited from 2016 to 2021.

Currently the VP of Business Operations & Site Lead for Medtronic PLC’s Caesarea site (formerly Mazor Robotics), Sharon is medical device veteran with extensive financial and business management experience in developing successful companies.

Currently the VP of Business Operations & Site Lead for Medtronic PLC’s Caesarea site (formerly Mazor Robotics), Sharon is medical device veteran with extensive financial and business management experience in developing successful companies.

Mr. Chan has been a private equity executive for the past three decades, managing and leading more than 80 investment projects supporting company growth via funding and synergistic mergers and acquisitions. Since March 2021, he has been the Director of Samena Capital, a principal investment group, headquartered in Dubai, with three private equity funds and $390 million in assets under management, and was a Senior Managing Director and Head of Asia of Samena Capital Hong Kong Limited from 2016 to 2021.

Mr. Yonatan Malca has served on our board of directors as an external director since September 2025. is the chief executive officer and a director at NanoGhost Ltd., a private biotechnology company. He serves on the board of directors of Entera Bio (NASDAQ: ENTX) and holds additional board positions at BeamMed Ltd., a private medical device company, Jungo Connectivity (TASE: JNGO), and Unicorn Technologies (TASE: UNCT). Mr. Malca holds a B.A. in Economics and Statistics and an M.A. in Economics and Finance, both from Bar-Ilan University in Israel.